The presidents and CEOs of both companies said they believe their roughly $52 billion combination will reduce healthcare costs, expand choice and improve the patient experience, including outcomes.
Completion of the transaction remains subject to certain state regulatory approvals and filings, and the satisfaction of all closing conditions. Shareholders voted to approve the deal Aug. 2, despite opposition from activist investor Carl Icahn.
The deal is slated to close by the end of 2018.
More articles on transactions and valuations:
Jefferson, Einstein Healthcare ink definitive merger agreement
Shuttered Ohio hospital considering surprise purchase offer
UNC Health Care divests 351-bed hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
